Medicare Enrolled

Dr. Roman Ostrowski, M.D.

Pulmonary Disease · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
242 EAST 19TH STREET, New York, NY 10003
2124756249
In practice since 2007 (19 years)
NPI: 1154459030 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ostrowski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ostrowski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ostrowski

Dr. Roman Ostrowski is a pulmonary disease specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ostrowski performed 2,907 Medicare services across 1,527 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ostrowski received a total of $9,786 from 28 pharmaceutical and/or device companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ostrowski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 12% volume in NY $9,786 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,907
Medicare services
Top 12% in NY for pulmonary disease
1,527
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~153 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
766 $76 $250
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
716 $109 $300
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
280 $35 $200
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
143 $8 $20
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
112 $49 $200
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
105 $1 $20
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
104 $13 $100
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
94 $12 $30
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
81 $3 $15
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
61 $146 $300
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
55 $40 $300
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
54 $53 $300
Annual depression screening 51 $21 $70
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
48 $80 $120
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
41 $35 $40
Injection, methylprednisolone acetate, 40 mg 39 $6 $20
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
38 $51 $90
Quadrivalent influenza vaccine, cell culture-derived
A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods.
30 $32 $50
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
30 $149 $250
Home visit, established patient, moderate complexity
A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service.
30 $106 $200
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
18 $30 $100
Quadrivalent influenza vaccine, preservative-free
A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose.
11 $22 $50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,786
Total received (2018-2024)
Avg $1,398/year across 7 years
Top 19% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
437
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,597 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$189 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,472
2023
$1,422
2022
$1,965
2021
$1,416
2020
$1,552
2019
$1,117
2018
$842

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$668
GENZYME CORPORATION
$250
GlaxoSmithKline, LLC.
$191
Regeneron Healthcare Solutions, Inc.
$153
Gilead Sciences, Inc.
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Lilly USA, LLC
$23
Amgen Inc.
$18
E.R. Squibb & Sons, L.L.C.
$16
Top 3 companies account for 75.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,019
GlaxoSmithKline, LLC.
$1,240
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,163
GENZYME CORPORATION
$1,004
Gilead Sciences, Inc.
$698
Regeneron Healthcare Solutions, Inc.
$692
Janssen Pharmaceuticals, Inc
$403
Amgen Inc.
$265
Merck Sharp & Dohme Corporation
$139
PFIZER INC.
$122
Insmed, Inc.
$112
Mylan Specialty L.P.
$100
Allergan, Inc.
$96
AbbVie Inc.
$86
Lilly USA, LLC
$86
IDORSIA PHARMACEUTICALS US INC
$80
SANOFI-AVENTIS U.S. LLC
$77
Electromed, Inc.
$75
ABBVIE INC.
$66
Teva Pharmaceuticals USA, Inc.
$48
Novartis Pharmaceuticals Corporation
$44
AbbVie, Inc.
$44
Philips Electronics North America Corporation
$29
Currax Pharmaceuticals LLC
$29
Amarin Pharma Inc.
$19
Genentech USA, Inc.
$18
E.R. Squibb & Sons, L.L.C.
$16
Almatica Pharma LLC
$14
Top 3 companies account for 55.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AUSTEDO · Arikayce · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · CAMZYOS · CONTRAVE · Creon · DIFICID · DUPIXENT · ELIQUIS · EMGALITY · FARXIGA · FASENRA · GRALISE · INVOKANA · JANUVIA · JARDIANCE · MOUNJARO · NUCALA · OFEV · Otezla · QULIPTA · QUVIVIQ · SMARTVEST · SPIRIVA RESPIMAT · SYMBICORT · SYNTHROID · TEZSPIRE · TRELEGY ELLIPTA · UBRELVY · VRAYLAR · Vascepa · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in New York?
Compare pulmonary diseases in the New York area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
645
Per 100K population
39.6
County median income
$104,553
Nearest hospital
NY EYE AND EAR INFIRMARY OF MOUNT SINAI
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ostrowski is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NY), with low-engagement industry engagement in the top 19% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ostrowski experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ostrowski performed 766 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ostrowski receive payments from pharmaceutical companies?
Yes. Dr. Ostrowski received a total of $9,786 from 28 companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ostrowski's costs compare to other pulmonary diseases in New York?
Dr. Ostrowski's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ostrowski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →